IRINOTECAN Teva liquid 100 mg/5ml flac
7680592170065
CH-59217
L01CE02
07.16.1.
1 / 2
google
Details
- Product number
- 5921702
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- irinotecani hydrochloridum trihydricum 100 mg, sorbitolum 225 mg, acidum (S)-lacticum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 0.431.
Articles (1)
Irinotecan-Teva liquid 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
225.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.431 | Substance | HBESI |
Reimbursement information
Public price
CHF 115.85
Specialties list
Yes
Generic
Yes
SL addition date:
01/08/2009
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 59217
- Drug name
- Irinotecan-Teva liquid, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01CE02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 06/05/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IRINOTECAN Teva liquid 100 mg/5ml flac
- Description (DE)
- IRINOTECAN Teva liquid 100 mg/5ml Durchstf
- Market launch
- 06/05/2009
- Narcotic (BTM)
- No